🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Mark the calendar for February 9th at 2pm ET for the CBSSM seminar with Laila Gharzai MD LLM of Northwestern Feinberg School of Medicine! Northwestern Medicine Michigan Medicine UMich Rad Onc Michigan Public Health U-M IHPI

Had a fantastic time today chatting with my Center for Bioethics & Social Sciences in Medicine folks today on financial toxicity research I’ve done with Reshma Jagsi, ways we can mitigate this devastating phenomenon…and experiencing my first zoom bomb!

Don’t miss the Lurie Cancer Center Multidisciplinary Head & Neck Symposium Dec. 2-3 Northwestern Medicine. The agenda features internationally-recognized experts in the diagnosis, treatment and rehabilitation of #HeadandNeckCancer patients: cancer.northwestern.edu/events/profess… #LurieHNC #HNCSM #CME

Financial impact of therapies should be measured. Patients who are informed of therapy implications—efficacy, side effects, cost, & financial impact—are able to select the best cancer treatment for themselves. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… Laila Gharzai MD LLM Reshma Jagsi CC: Vivek Subbiah, MD

We are ✨ECSTATIC✨ to have you all join us TOMORROW for Northwestern's 5th annual Women in Medicine conference! While online registration is closed, onsite registration will be available during the conference! 🎉Looking forward to seeing you all🎉

Read our April 15 issue! 📗 acsjournals.onlinelibrary.wiley.com/toc/10970142/2… ✔️ Top advances in hepatobiliary cancer by @TimGreten & Coffman-D’Annibale ✔️ Bev Green on DIP & nonadherence to health-protective behaviors ✔️ Laila Gharzai MD LLM Reshma Jagsi on financial toxicity & clinical trial design

Original Article: “Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer,” by Laila Gharzai MD LLM et al. eviden.cc/3zeUxg1 #OncoAlert #MedTwitter

LCRF Together Chicago is June 6 at The Ivy Room! Join our gathering & educational event with Drs. Nisha Mohindra, Jessica Donington, Laila A. Gharzai, & Melanie M. Smith; and moderator Ivy Elkins. Refreshments 5:30 PM; panel 6:30 PM. RSVP: LCRF.org/togetherchicago. #LungCancer

The FACT-HN-RAD offers a means to serially monitor patients with radiation therapy-related adverse effects and recovery over time in both the clinical and research settings. ja.ma/3sfS84e Laila Gharzai MD LLM Michelle Mierzwa

Surrogate endpoints for HPV+ HN cancer; an analysis of 5 NRG Oncology studies. LRPFS, DMFS, and PFS seem to fit the bill. authors.elsevier.com/c/1ifvZ5EIIgPd… Laila Gharzai MD LLM

Excited to share our work showing the first validation of surrogate endpoints in HPV+ oropharyngeal cancer! We show that LRPFS, DMFS, and PFS correlate with 5yr OS. Important for trial design in this evolving dx space Michelle Mierzwa Matthew Schipper NRG Oncology sciencedirect.com/science/articl…

Check out our paper on screening for financial toxicity in patients with cancer! #LeilaMady Laila Gharzai MD LLM Johns Hopkins OHNS Preventing and addressing FT begins with detecting it. We discuss the available tools, best practices, and common risk factors. jacr.org/article/S1546-…

Poster #282 right now in the exhibit hall!

OncLive.com Face-Off between University of Chicago Hematology/Oncology and Northwestern Medicine ! Debated lung cancer, while discussing our rivalry! Purple vs Maroon! Faith Abodunrin MD Jyoti D Patel Laila Gharzai MD LLM Divya Gupta, MD With judges Roy Herbst Edward S. Kim, MD, MBA, FACP, FASCO Joshua Sabari, MD

Short summary PRO measures offer the opportunity to frequently screen patients undergoing treatment without unduly burdening patients. We show that FACT GP5, assessing side effect bother, is a promising summary measure for head/neck cancer patients. link.springer.com/article/10.100…

Asking patients for guidance based on their lived experience is key, says Lurie Cancer Center's Laila Gharzai, MD, (Laila Gharzai MD LLM), co-author of a recent study about #financialtoxicity screening preferences in JCO Oncology Practice. "They've actually been through it."

Our team demonstrates the first ever validation of COST Item 12 as a single item screening measure for financial toxicity—can be used as a brief, single item screener with excellent sensitivity for detecting patients at high risk of financial distress. ascopubs.org/doi/10.1200/OP…

Unmet needs such as transport and finances forcing cancer patients to miss imaging appointments. UC Irvine School of Medicine American College of Radiology JACR Laila Gharzai MD LLM ow.ly/cBkV50VyVRT